{"id":32624,"date":"2020-07-28T15:33:48","date_gmt":"2020-07-28T14:33:48","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32624"},"modified":"2023-04-29T13:43:50","modified_gmt":"2023-04-29T12:43:50","slug":"paul-whittaker","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/","title":{"rendered":"Paul Whittaker"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Paul Whittaker<\/h2>\n<h4>Vice President, Discovery Research at hVIVO<\/h4>\n\t<p>Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.<\/p>\n<p>Previously Unit Head for pre-clinical biomarkers in the Respiratory Disease Area of the Novartis Institutes for Biomedical Research in the UK with experience in a range of activities from target identification and validation, through lead identification and optimisation to biomarker development for clinical trials. Prior to that 14 years as an academic researcher, including 7 years as a Research Lecturer at Southampton University Medical School.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2.jpeg\" alt=\"Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2.jpeg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2-201x300.jpeg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2-686x1024.jpeg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2-768x1146.jpeg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2-630x940.jpeg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2-420x627.jpeg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile_2-315x470.jpeg 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Utilising human challenge studies to accelerate the development of new therapies for respiratory disease\n\t<\/h3>\n<ul>\n<li>Human models of disease as a way to better understand human pathology<\/li>\n<li>Disease in motion &#8211; the power of clinical and molecular time course data sets and matched clinical samples<\/li>\n<li>Data mining to accelerate drug target and biomarker discovery<\/li>\n<\/ul>\n\t<a href=\"https:\/\/sociopharma.com\/\" target=\"_blank\" role=\"button\" rel=\"noopener\">\n\t\t\t\t\tPresentation available only at SocioPharma.com\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/hvivo.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/hvivo.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/paul-whittaker-66986512\/\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Paul Whittaker Vice President, Discovery Research at hVIVO Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease. Previously Unit Head for pre-clinical biomarkers in the Respiratory Disease Area of the Novartis&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32625,"parent":32539,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-32624","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Paul Whittaker &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paul Whittaker &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-29T12:43:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/\",\"name\":\"Paul Whittaker &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg\",\"datePublished\":\"2020-07-28T14:33:48+00:00\",\"dateModified\":\"2023-04-29T12:43:50+00:00\",\"description\":\"Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Companion Diagnostics &#038; Biomarkers 2017 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Paul Whittaker\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paul Whittaker &#8226; BioTech Pharma Summit","description":"Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/","og_locale":"en_US","og_type":"article","og_title":"Paul Whittaker &#8226; BioTech Pharma Summit","og_description":"Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2023-04-29T12:43:50+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/","name":"Paul Whittaker &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg","datePublished":"2020-07-28T14:33:48+00:00","dateModified":"2023-04-29T12:43:50+00:00","description":"Currently Vice President, Discovery Research at hVIVO (formerly RetroScreen Virology Ltd) with responsibility for strategic direction and leadership of scientific activities aimed at identifying and developing drug targets and biomarkers for respiratory disease.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Paul_Whittaker_hvivo_BioTech_Pharma_Summit_Profile.jpeg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/paul-whittaker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Companion Diagnostics &#038; Biomarkers 2017 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/"},{"@type":"ListItem","position":3,"name":"Paul Whittaker"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=32624"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32624\/revisions"}],"predecessor-version":[{"id":38227,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32624\/revisions\/38227"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32539"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/32625"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=32624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}